[Fundamental cardiovascular effects of the Ca++ antagonistic coronary drug fendiline (author's transl)].
D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D002118:Calcium / Q000037:antagonists & inhibitors* / Q000378:metabolism; D003326:Coronary Circulation / Q000187:drug effects; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D008564:Membrane Potentials / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D010627:Phenethylamines / Q000494:pharmacology*; D011817:Rabbits; D013552:Swine; D014666:Vasomotor System / Q000187:drug effects
D010627:Phenethylamines; D002118:Calcium
Fundamentale Herz- und Gefsswirkungen des Ca%%-antigonistischen Koronartherapeutikums Fendilin